Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide.
Erkan TopkanAli Ayberk BesenHuseyin MertsoyluAhmet KucukBerrin PehlivanUgur SelekPublished in: International journal of inflammation (2020)
Present results suggested the pretreatment CRP/Alb as a significant and independent inflammation-based index which can be utilized for further prognostic lamination of GBM patients.